All filters
Videos
What challenges remain in viral hepatitis | Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
HCV elimination program in Georgia: Successes and challenges | Nikoloz Chkhartishvili, MD, MS, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Antifibrotics and fatty liver drugs in the pipeline | Sanjay Bhagani, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
NASH and NAFLD in HIV: same or different? | Mariana Machado, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Non liver and survival benefits of SVR in HCV | Marion Peters, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
The use of HIV+ or HCV+ organs in transplantation | Stefano Fagiuoli, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Are there any special populations in treatment of HCV left? | Douglas Dieterich, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Pharmacologist's perspective | David Back, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Virologist's perspective | Charles Boucher, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Special considerations before / during / after DAA therapy | Kosh Agarwal, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
HBV cure: what is coming in 5 – 10 years? | Patrick Kennedy, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
EASL highlights 2017 | Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Management of end-stage liver disease in HIV patients | Ana Morbey, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
News on hepatitis delta and HIV infections | Vincent Soriano, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Hepatitis E in HIV | Kenneth Sherman, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Management of HCV in intravenous drug users: special considerations | Rui Sarmento e Castro, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Hepatitis E in HIV- Kenneth Sherman, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
News on hepatitis delta and HIV infections- Vincent Soriano, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Management of HCV in intravenous drug users: special considerations- Rui Sarmento e Castro, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
EASL highlights 2017- Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Management of end-stage liver disease in HIV patients- Ana Morbey, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
New insights in management of HIV/HBV co-infected patients- Juan Berenguer, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
HBV cure: what is coming in 5 – 10 years?- Patrick Kennedy, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017